Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck: Appeal statement
The Institute has arranged a hearing for 3 appeals received against the Final Appraisal Determination and Guidance on this technology.
As set out in the Guidance for Appellants members of the public, including consultees and commentators for this appraisal, and the press, may request to attend the hearing. The number of observers admitted to the hearing will be limited to a number appropriate for the venue, and priority will be given to members of the public who are not employed by the appellants.
A hearing will be held at NICE, MidCity Place, 71 High Holborn, London, WC1V 6NA on 22nd August 2007 starting at 10am.Members of the public will be able to register to attend the appeal hearing using this page from 11th July 2007. The Institute will not accept early requests to attend.
The name(s) of the appellants will be published on this page on the day of the appeal. The Institute will not comment on speculation as to the identity of appellants prior to publication of this information on the Institute's website.
This page was last updated: 30 March 2010